Farmaceuticos ComunitariosPub Date : 2024-09-17eCollection Date: 2024-10-15DOI: 10.33620/FC.2173-9218.(2024).21
Diana Laura García Martín
{"title":"[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients].","authors":"Diana Laura García Martín","doi":"10.33620/FC.2173-9218.(2024).21","DOIUrl":"10.33620/FC.2173-9218.(2024).21","url":null,"abstract":"<p><strong>Introduction: </strong>The Medication Review in the Pharmacotherapeutic Follow-up Service (PFS) seems to be an effective method to study long-term drug safety in the outpatient setting. The adverse drug reactions (ADRs) that are not immediately obvious are difficult to identify and sometimes can be confused with a more common condition. Misdiagnosis by not associating the symptoms of AMR to its pharmacological cause causes its masking and hinders its detection.</p><p><strong>Objective: </strong>Detect in the SFT service the diagnostic errors related to the non-detection of adverse reactions to statins.</p><p><strong>Material and methods: </strong>The data obtained from the medication review at the Pharmacotherapeutic Follow-up Service (PFS) were pooled for analysis. The patients who received the service were selected with the \"DLGM screening\" tool, an acronym \"Diagnosis load Generated by Medications\", that allows us to describe adverse drug reactions (ADRs), when their symptoms are attributed to a pathology, without considering medication as a possible underlying cause.Only the results of patients over 60 years of age, who after a prolonged period of statin use gradually presented musculoskeletal disorders (MSD) and other symptoms theoretically described as possible ADRs, are shown.</p><p><strong>Results: </strong>In 66 % of the cases, corresponding to 14 patients out of a total of 21 studied, the physician modified the treatment and in 92% of these cases there was improvement and a decrease of the consumption of analgesics drug, anti-inflammatory and other drugs used to treat ADR symptoms.</p><p><strong>Conclusion: </strong>DLGM screening identified hidden AMRs in 62 % of patients.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"5-14"},"PeriodicalIF":0.6,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2024-09-17eCollection Date: 2024-10-15DOI: 10.33620/FC.2173-9218.(2024).27
A Montero-Gómez, A Sánchez Pozo
{"title":"[Selection of pharmacogenomic variants and methodology for their use in community pharmacy].","authors":"A Montero-Gómez, A Sánchez Pozo","doi":"10.33620/FC.2173-9218.(2024).27","DOIUrl":"10.33620/FC.2173-9218.(2024).27","url":null,"abstract":"<p><p>Regulatory agencies such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) recognize pharmacogenetics as a key tool in their pharmacological guidelines for pharmaceutical counseling. In this context, community pharmacies play a crucial role in addressing this healthcare need, which could lead to a significant improvement in patients' quality of life by preventing ineffective or contraindicated treatments.In this work, we conducted a systematic review of the available scientific evidence regarding druggene interactions relevant to community pharmacy. We identified the main genes and polymorphisms associated with treatment response and adverse effects in primary care. Finally, we propose a model for implementing pharmacogenetic services in community pharmacies.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"61-82"},"PeriodicalIF":0.6,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Material para farmacéuticos. Citisiniclina. Porque lo Natural es dejar de fumar, hay manera de ayudar a tus pacientes","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.072","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.072","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"160 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Abordaje conjunto Médico – Farmacéutico del paciente con Trastorno Depresivo. Guía de Actuación","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.076","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.076","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Material para pacientes. Citisiniclina. Porque lo Natural es dejar de fumar","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.073","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.073","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"188 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Infografía para pacientes: La Importancia de la Vacunación en el adulto, ¿Te apuntas al reto?","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.077","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.077","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Infografía para farmacéuticos: Farmacogenética en Anticoagulantes: Una Guía Básica para Farmacéuticos Comunitarios","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.075","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.075","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}